Downregulation of SATB-1 decreased the IC50 values in pancreatic cancer cells, thus indicating that SATB-1 played an active role in promoting gemcitabine resistance in pancreatic cancer cells. This evidence concerns the gene SATB1 and familial pancreatic carcinoma.